학술논문
Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma
Document Type
Article
Author
Source
In Annals of Oncology February 2024 35(2):211-220
Subject
Language
ISSN
0923-7534